z-logo
Premium
A rare case of a gabapentin‐induced cardiomyopathy
Author(s) -
Tellor Katie B.,
NgoLam Richard,
Badran Dena,
Armbruster Anastasia L.,
Schwarze Martin W.
Publication year - 2019
Publication title -
journal of clinical pharmacy and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.622
H-Index - 73
eISSN - 1365-2710
pISSN - 0269-4727
DOI - 10.1111/jcpt.12840
Subject(s) - gabapentin , postherpetic neuralgia , medicine , cardiomyopathy , ejection fraction , stenosis , anesthesia , cardiology , heart failure , surgery , neuropathic pain , pathology , alternative medicine
Summary What is known and objective Gabapentin, a γ‐aminobutyric acid derivative, is used for the treatment of partial onset seizures, postherpetic neuralgia, diabetic neuropathy and a host of other neurological disorders. Case description A 44‐year‐old woman with spinal stenosis was prescribed gabapentin for pain. Two months after initiating therapy, she was diagnosed with a new‐onset non‐ischaemic cardiomyopathy with an ejection fraction of 36% measured on a transthoracic echocardiogram. What is new and Conclusion A patient with suspected gabapentin‐induced cardiomyopathy is reported. However, to date, gabapentin therapy has not been associated with risk of the developing a cardiomyopathy.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom